Telehealth Giant Hims Wants to Test Every Dude for Low Testosterone
THE SO WHAT
A telehealth platform expanding into testosterone replacement and controlled substances turns online care into a higher-regulation, higher-liability business. Competitors should expect more scrutiny on prescribing practices and need tighter clinical governance if they follow this path.
READ THE SOURCE
MORE FROM THE WIRE
Tech & InnovationAndroid 17 QPR3 Beta 2: Everything new, everything fixed
A non-seismic Android 17 QPR3 beta is a reminder that mobile OS innovation is now mostly about stability and incremental polish. For app teams, the priority is regression testing and compatibility—not chasing new APIs that will move the needle this quarter.
Tech & InnovationInternet Archive, Wikipedia outages: What we know
Simultaneous outages at the Internet Archive and Wikipedia expose how much research, reference, and even compliance workflows depend on a few free, centralized services. If your operations assume those sites are “always there,” add local mirrors, caches, or alternative sources before the next disruption.
Shoppers turn to Amazon for fresh produce and seafood, helping it take market share from supermarkets
Amazon gaining fresh produce and seafood share means the last defensible supermarket category—perishables—is now under direct attack. CPGs and regional grocers need to treat Amazon as a primary shelf, not an adjunct channel, and rework pricing, promo, and data-sharing strategies accordingly.
Tech & InnovationA SpaceX-Tesla Merger? Why Elon Musk Thinks It’s a Good Idea
A combined Tesla–SpaceX would concentrate EVs, energy storage, launch, and satellite networks under one balance sheet—blurring the line between auto OEM, utility, and space infra. If this advances, vendors and partners should expect tighter cross-company integration and a single negotiating counterparty for everything from batteries to ground stations.